Clinical Features/Indices | Mean (± SD), or n (%) |
---|---|
Age at presentation, yrs | 42.5 ± 13.0 |
Age at diagnosis, yrs | 33.2 ± 12.9 |
Duration of illness, yrs | 9.3 ± 8.8 |
Race (%) | |
African American | 94/167 (53.5) |
Caucasian | 42/167 (30.2) |
Hispanic | 21/167 (12.5) |
Asian | 10/167 (6.0) |
Sex (%) | |
Female | 156/167 (93.5) |
Male | 11/167 (6.5) |
Disease activity and damage | |
SLEDAI, mean | 6.2 ± 5.7 |
SDI, mean | 2.0 ± 2.0 |
SF-36 subscales (0–100) | |
Physical function | 55.4 ± 30.4 |
Role-physical | 38.2 ± 41.3 |
Bodily pain | 51.5 ± 25.9 |
General health | 43.1 + 20.6 |
Vitality | 45.1 ± 22.7 |
Social functioning | 59.6 ± 27.1 |
Role emotional | 57.7 ± 45.45 |
Mental health | 68.1 ± 21.21 |
MCS | 51.9 ± 8.9 |
PCS | 35.6 ± 10.8 |
EQ-5D index (0–1) | 0.72 ± 0.19 |
EQ-5D VAS (0–100) | 68.7 ± 20.46 |
SF-6D (0.296–1) | 0.64 ± 0.14 |
SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; SDI: Systemic Lupus International Collaborating Clinics (SLICC) Damage Index; SF-36: Medical Outcomes Study Short-Form 36; MCS/PCS: Mental/Physical Component Scores; EQ-SD: EuroQol; SF-6D: Short Form-6D; VAS: Visual analog scale.